BIOWKS Stock Overview
A biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Bio-Works Technologies AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.96 |
| 52 Week High | SEK 9.34 |
| 52 Week Low | SEK 0.92 |
| Beta | 1.14 |
| 11 Month Change | -25.67% |
| 3 Month Change | -60.87% |
| 1 Year Change | -88.69% |
| 33 Year Change | -94.64% |
| 5 Year Change | -88.45% |
| Change since IPO | -92.33% |
Recent News & Updates
Recent updates
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth
Dec 25
Companies Like Bio-Works Technologies (STO:BIOWKS) Are In A Position To Invest In Growth
Aug 30We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth
Feb 21We Think Bio-Works Technologies (STO:BIOWKS) Can Afford To Drive Business Growth
Oct 25We Think Bio-Works Technologies (STO:BIOWKS) Can Easily Afford To Drive Business Growth
May 10Bio-Works Technologies (STO:BIOWKS) Is In A Strong Position To Grow Its Business
Sep 27Is Bio-Works Technologies (STO:BIOWKS) In A Good Position To Invest In Growth?
May 11Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Have Been Selling
Mar 20How Much Are Bio-Works Technologies AB (publ) (STO:BIOWKS) Insiders Taking Off The Table?
Dec 05
Shareholder Returns
| BIOWKS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -3.1% | 0.6% | 1.6% |
| 1Y | -88.7% | 22.1% | 25.5% |
Return vs Industry: BIOWKS underperformed the Swedish Medical Equipment industry which returned 22.1% over the past year.
Return vs Market: BIOWKS underperformed the Swedish Market which returned 25.5% over the past year.
Price Volatility
| BIOWKS volatility | |
|---|---|
| BIOWKS Average Weekly Movement | 17.5% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: BIOWKS's share price has been volatile over the past 3 months.
Volatility Over Time: BIOWKS's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 33 | Lone Carlbom | www.bio-works.com |
Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography resins. The company’s products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.
Bio-Works Technologies AB (publ) Fundamentals Summary
| BIOWKS fundamental statistics | |
|---|---|
| Market cap | SEK 37.37m |
| Earnings (TTM) | -SEK 46.96m |
| Revenue (TTM) | SEK 34.84m |
1.1x
P/S Ratio-0.8x
P/E RatioIs BIOWKS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOWKS income statement (TTM) | |
|---|---|
| Revenue | SEK 34.84m |
| Cost of Revenue | SEK 10.44m |
| Gross Profit | SEK 24.40m |
| Other Expenses | SEK 71.36m |
| Earnings | -SEK 46.96m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 21, 2025
| Earnings per share (EPS) | -1.20 |
| Gross Margin | 70.03% |
| Net Profit Margin | -134.77% |
| Debt/Equity Ratio | 0% |
How did BIOWKS perform over the long term?
See historical performance and comparison